JP2022534434A5 - - Google Patents

Info

Publication number
JP2022534434A5
JP2022534434A5 JP2021571021A JP2021571021A JP2022534434A5 JP 2022534434 A5 JP2022534434 A5 JP 2022534434A5 JP 2021571021 A JP2021571021 A JP 2021571021A JP 2021571021 A JP2021571021 A JP 2021571021A JP 2022534434 A5 JP2022534434 A5 JP 2022534434A5
Authority
JP
Japan
Prior art keywords
pyrimidine
pyrido
amine
methyl
ethyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021571021A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022534434A (ja
JP7797204B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2020/064915 external-priority patent/WO2020239953A1/en
Publication of JP2022534434A publication Critical patent/JP2022534434A/ja
Publication of JP2022534434A5 publication Critical patent/JP2022534434A5/ja
Application granted granted Critical
Publication of JP7797204B2 publication Critical patent/JP7797204B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021571021A 2019-05-31 2020-05-28 P2x3阻害剤としてのピリドピリミジン誘導体 Active JP7797204B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP19177610.3 2019-05-31
EP19177610 2019-05-31
EP19201165.8 2019-10-02
EP19201165 2019-10-02
PCT/EP2020/064915 WO2020239953A1 (en) 2019-05-31 2020-05-28 Pyridopyrimidines derivatives as p2x3 inhibitors

Publications (3)

Publication Number Publication Date
JP2022534434A JP2022534434A (ja) 2022-07-29
JP2022534434A5 true JP2022534434A5 (cg-RX-API-DMAC7.html) 2023-06-06
JP7797204B2 JP7797204B2 (ja) 2026-01-13

Family

ID=70857198

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021571021A Active JP7797204B2 (ja) 2019-05-31 2020-05-28 P2x3阻害剤としてのピリドピリミジン誘導体

Country Status (11)

Country Link
US (1) US12606562B2 (cg-RX-API-DMAC7.html)
EP (1) EP3976609A1 (cg-RX-API-DMAC7.html)
JP (1) JP7797204B2 (cg-RX-API-DMAC7.html)
KR (1) KR102923602B1 (cg-RX-API-DMAC7.html)
CN (1) CN114222741B (cg-RX-API-DMAC7.html)
AU (1) AU2020281924B2 (cg-RX-API-DMAC7.html)
BR (1) BR112021020279A2 (cg-RX-API-DMAC7.html)
CA (1) CA3136024A1 (cg-RX-API-DMAC7.html)
MA (1) MA56020A (cg-RX-API-DMAC7.html)
MX (1) MX2021014116A (cg-RX-API-DMAC7.html)
WO (1) WO2020239953A1 (cg-RX-API-DMAC7.html)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MA56022A (fr) 2019-05-31 2022-04-06 Chiesi Farm Spa Dérivés d'amino quinazoline servant d'inhibiteurs de p2x3
KR102923602B1 (ko) 2019-05-31 2026-02-06 키에시 파르마슈티시 엣스. 피. 에이. P2x3 억제제로서 피리도피리미딘 유도체
WO2022160931A1 (zh) * 2021-01-28 2022-08-04 浙江海正药业股份有限公司 吡啶并嘧啶类衍生物及其制备方法和用途
JP2026517300A (ja) 2023-05-22 2026-05-28 キエシ・フアルマチエウテイチ・ソチエタ・ペル・アチオニ P2x3阻害剤を調製するための方法および中間体
WO2026143058A1 (en) * 2024-12-23 2026-07-02 Neolaia Inc. Pyridopyrimidine compounds useful as cd38 inhibitors

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH31122A (en) 1993-03-31 1998-02-23 Eisai Co Ltd Nitrogen-containing fused-heterocycle compounds.
JP4342007B2 (ja) * 1998-08-10 2009-10-14 大日本住友製薬株式会社 キナゾリン誘導体
PT1725540E (pt) 2004-03-05 2012-11-29 Hoffmann La Roche Diaminopirimidinas como antagonistas de p2x3 e p2x2/3
SI1924264T1 (sl) * 2005-09-01 2013-12-31 F. Hoffmann-La Roche Ag Diaminopirimidini kot modulatorji p2x3 in p2x2/3
WO2007134986A1 (en) 2006-05-23 2007-11-29 F. Hoffmann-La Roche Ag Pyridopyrimidinone derivatives
ES2596706T3 (es) 2006-06-29 2017-01-11 F. Hoffmann-La Roche Ag Arilamidas con sustitución de tetrazol
TW200840584A (en) 2006-12-26 2008-10-16 Gilead Sciences Inc Pyrido(3,2-d)pyrimidines useful for treating viral infections
WO2008123963A1 (en) 2007-04-02 2008-10-16 Renovis, Inc. Pyrid-2-yl fused heterocyclic compounds, and compositions and uses thereof
US8076345B2 (en) 2007-04-17 2011-12-13 Evotec Ag 2-cyanophenyl-7,8-dihydro-5H-pyrido[4,3-d]pyrimidine compounds, compositions and uses thereof
WO2009110985A2 (en) 2008-02-29 2009-09-11 Renovis, Inc. Amide compounds, compositions and uses thereof
US20110237578A1 (en) 2008-09-18 2011-09-29 Zhi-Liang Wei Amide compounds, compositions and uses thereof
JP2012504157A (ja) 2008-09-30 2012-02-16 アストラゼネカ アクチボラグ 複素環式jakキナーゼ阻害剤
SG173647A1 (en) 2009-02-13 2011-10-28 Shionogi & Co Novel triazine derivative and pharmaceutical composition containing same
WO2011041655A1 (en) * 2009-10-01 2011-04-07 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Quinazolin-4-amine derivatives; and methods of use
WO2012064973A2 (en) * 2010-11-10 2012-05-18 Infinity Pharmaceuticals, Inc. Heterocyclic compounds and uses thereof
EP2938600B1 (en) 2012-12-27 2017-01-25 F. Hoffmann-La Roche AG Comt inhibitors
WO2016053794A1 (en) 2014-09-30 2016-04-07 Bristol-Myers Squibb Company Quinazoline-based kinase inhibitors
WO2016084922A1 (ja) 2014-11-28 2016-06-02 塩野義製薬株式会社 1,2,4-トリアジン誘導体およびその医薬組成物
WO2016088838A1 (ja) 2014-12-04 2016-06-09 塩野義製薬株式会社 プリン誘導体およびその医薬組成物
CU24411B1 (es) 2014-12-09 2019-05-03 Bayer Ag Compuesto derivado de benzamida sustituida con 1,3-tiazol-2-ilo útil para el tratamiento de trastornos neurogénicos
WO2017011729A1 (en) 2015-07-16 2017-01-19 Patara Pharma, LLC Combination therapies for the treatment of lung diseases
CA2998742C (en) 2015-09-29 2023-08-29 Anthony P. FORD Diaminopyrimidine p2x3 and p2x2/3 receptor modulators for use in the treatment of cough
EP3380469B1 (en) * 2015-11-25 2022-03-16 Convergene Llc Bicyclic bet bromodomain inhibitors and uses thereof
CN106565684B (zh) 2016-03-18 2019-06-18 南方医科大学 6-吡唑取代喹唑啉类化合物及其衍生物、合成方法及其应用
JP6776378B2 (ja) 2016-06-30 2020-10-28 ギリアード サイエンシーズ, インコーポレイテッド Cotモジュレーターとしての4,6−ジアミノキナゾリン類およびその使用方法
GB201700814D0 (en) * 2017-01-17 2017-03-01 Liverpool School Tropical Medicine Compounds
TWI762634B (zh) 2017-05-05 2022-05-01 大陸商上海赫普化醫藥技術有限公司 胺基-芳基-苯甲醯胺化合物及其使用方法
DK3827005T3 (da) * 2018-07-25 2022-09-19 Faes Farma Sa Pyridopyrimidiner som histamin H4-receptorhæmmere
CN109721554A (zh) 2019-01-08 2019-05-07 贵州大学 一类4-氨基喹唑啉类化合物及其制备方法和应用
MA56022A (fr) * 2019-05-31 2022-04-06 Chiesi Farm Spa Dérivés d'amino quinazoline servant d'inhibiteurs de p2x3
KR102923602B1 (ko) 2019-05-31 2026-02-06 키에시 파르마슈티시 엣스. 피. 에이. P2x3 억제제로서 피리도피리미딘 유도체

Similar Documents

Publication Publication Date Title
US11197867B2 (en) Aminopyrimidinyl compounds
US11623921B2 (en) Indole carboxamide compounds
JP2022534751A5 (cg-RX-API-DMAC7.html)
JP2017512786A5 (cg-RX-API-DMAC7.html)
JP2023514872A5 (cg-RX-API-DMAC7.html)
JP2021502356A5 (cg-RX-API-DMAC7.html)
JP2019535664A5 (cg-RX-API-DMAC7.html)
JP2014531449A5 (cg-RX-API-DMAC7.html)
JP2012501312A5 (cg-RX-API-DMAC7.html)
JP2016523911A5 (cg-RX-API-DMAC7.html)
JP2017512794A5 (cg-RX-API-DMAC7.html)
RU2016141647A (ru) ИНГИБИТОРЫ TrkA КИНАЗЫ, ОСНОВАННЫЕ НА НИХ КОМПОЗИЦИИ И СПОСОБЫ
JP2016526576A5 (cg-RX-API-DMAC7.html)
RU2401265C2 (ru) Соединения и композиции в качестве ингибиторов протеинкиназы
JP2009529047A5 (cg-RX-API-DMAC7.html)
JP2017505794A5 (cg-RX-API-DMAC7.html)
JP2010513444A5 (cg-RX-API-DMAC7.html)
SI3106463T1 (en) Substituted pyrazolo(1,5-)pyrimidine compounds as trk kinase inhibitors
JP2017508766A5 (cg-RX-API-DMAC7.html)
JP2020511452A5 (cg-RX-API-DMAC7.html)
HRP20192151T1 (hr) Derivati izokromena kao inhibitori fosfoinozitid 3-kinaza
JP2016540803A5 (cg-RX-API-DMAC7.html)
JP2019530708A5 (cg-RX-API-DMAC7.html)
JP2020502230A5 (cg-RX-API-DMAC7.html)
RU2021138377A (ru) Производные пиридопиримидинов в качестве ингибиторов p2x3